• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: DEPUY INTERNATIONAL LTD - 8010379 UNK HIP FEMORAL HEAD METAL ASR; METAL FEMORAL HEAD

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

DEPUY INTERNATIONAL LTD - 8010379 UNK HIP FEMORAL HEAD METAL ASR; METAL FEMORAL HEAD Back to Search Results
Catalog Number UNK HIP FEMORAL HEAD METAL ASR
Device Problems Degraded (1153); Naturally Worn (2988); Osseointegration Problem (3003)
Patient Problems Foreign Body Reaction (1868); Hypersensitivity/Allergic reaction (1907); Unspecified Infection (1930); Necrosis (1971); Pain (1994); Osteolysis (2377); Inadequate Osseointegration (2646); Metal Related Pathology (4530)
Event Date 04/06/2021
Event Type  Injury  
Manufacturer Narrative
Product complaint # (b)(4).D4: the device catalog number is unknown; therefore, udi is unavailable.H6 component code: appropriate term/code not available (g07002) used to capture no findings available.The size of the article is too large to attach/submit with the 3500a submission.The citation of the article has been provided below: campbell p, park sh, ebramzadeh e.Semi-quantitative histology confirms that the macrophage is the predominant cell type in metal-on-metal hip tissues.J orthop res.2022 feb;40(2):387-395.Doi: 10.1002/jor.25040.Epub 2021 apr 6.Pmid: 33749015; pmcid: pmc9292819.Investigation summary: no device associated with this report was received for examination.The information received will be retained for potential series investigations if triggered by trend analysis, post market surveillance, or other events within the quality system.Depuy considers the investigation closed.Should additional information be received, the information will be reviewed and the investigation will be re-opened as necessary.Depuy synthes is submitting this report pursuant to the provisions of 21 cfr, part 803.This report may be based on information which depuy synthes has not been able to investigate or verify prior to the required reporting date.This report does not reflect a conclusion by fda, depuy synthes or its employees that the report constitutes an admission that the device, depuy synthes, or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial medwatch, a follow-up medwatch will be filed as appropriate.
 
Event Description
This complaint is from a literature source.The following literature cite has been reviewed: campbell p, park sh, ebramzadeh e.Semi-quantitative histology confirms that the macrophage is the predominant cell type in metal-on-metal hip tissues.J orthop res.2022 feb;40(2):387-395.Doi: 10.1002/jor.25040.Epub 2021 apr 6.Pmid: 33749015; pmcid: pmc9292819.Objective and methods: numerous studies have examined the histology of metal-on-metal hip tissues for evidence of a dose response to metal wear but have often reported inconclusive or contradictory findings.The aim of the present study was to address these discrepancies using multiple histological scoring methods to characterize the tissue features of one large group of revised metal-on-metal total hips.Periprosthetic tissues from 165 asr xl metal-on-metal hip revisions (dor 2011 to 2017) were examined for features of aseptic lymphocytic vasculitis associated lesions (alval) as rated using two scoring systems as well as rankings for macrophage and lymphocyte numbers, intracellular wear debris and necrosis.This complaint will capture the generalized results of the pathological and histological studies of the explanted products and tissue samples as well as two patient specific results.Lot, model and catalog number are not available, but the suspected depuy device possibly associated with reported adverse events: depuy asr xl including a cup, femoral component femoral sleeve, and unk depuy femoral stem.Adverse event(s) and provided interventions associated with depuy devices: generalized results: all 165 patients were revised to treat alval, soft tissue necrosis, metal wear, elevated blood metal ions, and corrosion at the stem/head trunnion junction.The following were additional findings during the revisions: 86 pain, 62 elevated blood metal ions, 24 unspecified loosening, 19 metallosis, 14 pseudotumor (hypersensitivity) , 6 osteolysis, 4 infection, 2 allergic reaction, tissue pathology results: 23 samples with identified tissue necrosis.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
UNK HIP FEMORAL HEAD METAL ASR
Type of Device
METAL FEMORAL HEAD
Manufacturer (Section D)
DEPUY INTERNATIONAL LTD - 8010379
st. anthony's road
leeds LS11 8DT
UK  LS11 8DT
Manufacturer (Section G)
DEPUY INT'L LTD. 8010379
st anthonys road
leeds LS11 8 DT
UK   LS11 8 DT
Manufacturer Contact
kate karberg
700 orthopaedic dr.
warsaw, IN 46581-0988
3035526892
MDR Report Key17279474
MDR Text Key318756525
Report Number1818910-2023-13729
Device Sequence Number1
Product Code KWA
Combination Product (y/n)N
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Literature,Health Professional
Reporter Occupation Other Health Care Professional
Remedial Action Recall
Type of Report Initial
Report Date 07/07/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue NumberUNK HIP FEMORAL HEAD METAL ASR
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 06/19/2023
Initial Date FDA Received07/07/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Removal/Correction NumberZ-1749/1816-2011
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-